FDA Clearance Tracker · K172932
True Flow Valvuloplasty Perfusion Catheter
Last checked: Nov 20, 2026Latest source record: Dec 13, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Dec 13, 2017
Substantially Equivalent
Time to decision
78 days
Received Sep 26, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K172932
- Device name
- True Flow Valvuloplasty Perfusion Catheter
- Applicant
- C.R. Bard, Inc.
- Applicant location
- Tempe, AZ
- Received
- Sep 26, 2017
- Decided
- Dec 13, 2017
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Balloon Aortic Valvuloplasty (OZT)
- Device class
- Class II
- Regulation
- 21 CFR 870.1255
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OZT. The earliest in FDA's data is DEN080015, decided Jun 11, 2012.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K172932
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for C.R. Bard, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261543 · Decided Sep 28, 2026 · 143 days after receipt
Device type: Mesh, Surgical, Absorbable, Abdominal Hernia (OWT) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.